Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-009793

Options or other derivatives

  • Director bought 625,200 shares at $1,000.00 ($200,000)

From the SEC's structured data for this filing

Trades in this filing

Waksal Harlan · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2010-06-02 Purchase : show line 1 in the form Common Stock Warrant +625,000 $0.35 2015-06-02 625,000 1,167,333 D
2010-06-02 Purchase : show line 2 in the form Series B Convertible Preferred Stock +200 $1,000.00 $200,000 $0.32 625,000 200 D
Loading xslF345X03/edgar.xml…